Current Psychopharmacology

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Modulation Effects of Piracetam and Ginkgo biloba on the Cognitive and Working Memory Functions: Psychometric Study

Volume:3   Issue: 2
Pp: 87-92
Hayder M. Alkuraishy, Ali I. Algareeb, Ali K. Albuhadilly and Basim M. ALmgoter
DOI: 10.2174/221155600302150302105355
Published on: 02 March, 2015

Pharmacological Treatment of Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review of Recent Data

Volume:3   Issue: 2
Pp: 93-107
Silvio Bellino, Marta Mirra, Elena Brignolo, Paola Bozzatello and Filippo Bogetto
DOI: 10.2174/2211556003666140618185450
Published on: 02 March, 2015

Increase in Antipsychotic Polypharmacy Treatment in Patients with Schizophrenia Between 1994-2000 and 2010

Volume:3   Issue: 2
Pp: 108-112
Deniz Ceylan, Ahmet Aktener, Berna B. Akdede and Koksal Alptekin
DOI: 10.2174/221155600302150302110310
Published on: 02 March, 2015

A Review of the Current Clinical Use of Quetiapine and Extended Release Quetiapine in the Management of Anxiety and Related Disorders

Volume:3   Issue: 2
Pp: 113-125
Martin A. Katzman, Melissa Furtado, Alexandra Copeland, Dina Tsirgielis, Christina D’Ambrosio, Leena Anand and Irvin Epstein
DOI: 10.2174/221155600302150302110735
Published on: 02 March, 2015

Antipsychotic-Induced Electrocardiographic Changes: A Comparative Study Between Olanzapine and Risperidone

Volume:3   Issue: 2
Pp: 126-131
Saeed S. Shafti and Parisa F. Jahromi
DOI: 10.2174/221155600302150302111019
Published on: 02 March, 2015

Olanzapine vs Aripiprazole in the Management of Borderline Personality Disorder

Volume:3   Issue: 2
Pp: 132-136
Saeed S. Shafti and Hamid Kaviani
DOI: 10.2174/2211556003666140912223626
Published on: 02 March, 2015

Safety Profile of the Use of Second Generation Antipsychotics in the Child and Adolescent Population

Volume:3   Issue: 2
Pp: 146-150
Michael Shapiro, Mariam Rahmani, Adrienne Eisner and Mathew Nguyen
DOI: 10.2174/221155600302150302112302
Published on: 02 March, 2015